Senellart H - Search Results

1

[Hepatocellular carcinoma: Increase in incidence or future plague?].

Raoul JL, Raimbourg J, Hiret S, Adhoute X, Senellart H. Raoul JL, et al. Among authors: senellart h. Bull Cancer. 2018 May;105(5):502-507. doi: 10.1016/j.bulcan.2018.02.003. Epub 2018 Mar 19. Bull Cancer. 2018. PMID: 29567280 Review. French.

2

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.

Bennouna J, Levy V, Sicard H, Senellart H, Audrain M, Hiret S, Rolland F, Bruzzoni-Giovanelli H, Rimbert M, Galéa C, Tiollier J, Calvo F. Bennouna J, et al. Among authors: senellart h. Cancer Immunol Immunother. 2010 Oct;59(10):1521-30. doi: 10.1007/s00262-010-0879-0. Epub 2010 Jun 19. Cancer Immunol Immunother. 2010. PMID: 20563721 Free PMC article. Clinical Trial.

3

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.

Conroy T, Yataghène Y, Etienne PL, Michel P, Senellart H, Raoul JL, Mineur L, Rives M, Mirabel X, Lamezec B, Rio E, Le Prisé E, Peiffert D, Adenis A. Conroy T, et al. Among authors: senellart h. Br J Cancer. 2010 Oct 26;103(9):1349-55. doi: 10.1038/sj.bjc.6605943. Epub 2010 Oct 12. Br J Cancer. 2010. PMID: 20940718 Free PMC article. Clinical Trial.

4

[Molecular biology of lung cancer series].

Hiret S, Senellart H, Bennouna J. Hiret S, et al. Among authors: senellart h. Rev Mal Respir. 2010 Oct;27(8):954-8. doi: 10.1016/j.rmr.2010.08.002. Rev Mal Respir. 2010. PMID: 20965409 Review. French.

5

Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.

Bennouna J, Senellart H, Hiret S, Vaissiere N, Douillard JY. Bennouna J, et al. Among authors: senellart h. Lung Cancer. 2011 Oct;74(1):30-4. doi: 10.1016/j.lungcan.2011.02.004. Epub 2011 Mar 3. Lung Cancer. 2011. PMID: 21371774

6

Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo.

Hamaï A, Pignon P, Raimbaud I, Duperrier-Amouriaux K, Senellart H, Hiret S, Douillard JY, Bennouna J, Ayyoub M, Valmori D. Hamaï A, et al. Among authors: senellart h. Cancer Res. 2012 Mar 1;72(5):1059-63. doi: 10.1158/0008-5472.CAN-11-3432. Epub 2012 Jan 17. Cancer Res. 2012. PMID: 22253231

7

[Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer].

Senellart H, Hiret S, Guerin-Meyer V, Bennouna J. Senellart H, et al. Bull Cancer. 2014 Jun;101(6):619-25. doi: 10.1684/bdc.2014.1984. Bull Cancer. 2014. PMID: 24977450 Review. French.

8

[KRAS mutation does not influence oxaliplatin or irinotecan efficacy, in association with bevacizumab, in first line treatment of metastatic colorectal cancer].

Cabart M, Frénel JS, Campion L, Ramée JF, Dupuis O, Senellart H, Hiret S, Douillard JY, Bennouna J. Cabart M, et al. Among authors: senellart h. Bull Cancer. 2016 Jun;103(6):541-51. doi: 10.1016/j.bulcan.2016.03.007. Epub 2016 May 5. Bull Cancer. 2016. PMID: 27155924 French.

9

Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study.

Cabart M, Frénel JS, Campion L, Ramée JF, Dupuis O, Senellart H, Hiret S, Douillard JY, Bennouna J. Cabart M, et al. Among authors: senellart h. Clin Colorectal Cancer. 2016 Dec;15(4):e165-e174. doi: 10.1016/j.clcc.2016.04.009. Epub 2016 May 7. Clin Colorectal Cancer. 2016. PMID: 27256668

10

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators. Aparicio T, et al. Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26. Eur J Cancer. 2018. PMID: 29807237 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters